These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34930269)
21. Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway. Liu D; Li K; Gong L; Fu L; Yang D Int J Pharm; 2023 Mar; 635():122728. PubMed ID: 36796659 [TBL] [Abstract][Full Text] [Related]
22. Nanoparticles Encapsulated in Red Blood Cell Membranes for Near-Infrared Second Window Imaging-Guided Photothermal-Enhanced Immunotherapy on Tumors. Ye J; Yu Y; Li Y; Yao B; Gu M; Li Y; Yin S ACS Appl Mater Interfaces; 2024 Jul; 16(27):34607-34619. PubMed ID: 38924764 [TBL] [Abstract][Full Text] [Related]
23. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622 [TBL] [Abstract][Full Text] [Related]
24. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation. Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356 [TBL] [Abstract][Full Text] [Related]
25. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy. Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723 [TBL] [Abstract][Full Text] [Related]
26. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer. Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479 [TBL] [Abstract][Full Text] [Related]
27. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy. Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312 [TBL] [Abstract][Full Text] [Related]
28. Engineered macrophage-derived cellular vesicles for NIR-II fluorescence imaging-guided precise cancer photo-immunotherapy. Lin Q; Wang Y; Wang L; Fan Z Colloids Surf B Biointerfaces; 2024 Mar; 235():113770. PubMed ID: 38330689 [TBL] [Abstract][Full Text] [Related]
29. A Polymer Multicellular Nanoengager for Synergistic NIR-II Photothermal Immunotherapy. Xu C; Jiang Y; Han Y; Pu K; Zhang R Adv Mater; 2021 Apr; 33(14):e2008061. PubMed ID: 33634897 [TBL] [Abstract][Full Text] [Related]
30. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726 [TBL] [Abstract][Full Text] [Related]
31. A relay-type innate immunity activation strategy involving water-soluble NIR-II AIEgen for boosted tumor photo-immunotherapy. Liu S; Sun Y; Yan D; Song W; Fu J; Wang S; Yang T; Zhu J; Zhu D; Wang D; Zhou F; Tang BZ Theranostics; 2024; 14(12):4667-4682. PubMed ID: 39239517 [No Abstract] [Full Text] [Related]
32. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy. Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039 [TBL] [Abstract][Full Text] [Related]
33. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor. Chen Z; Zhang Q; Zeng L; Zhang J; Liu Z; Zhang M; Zhang X; Xu H; Song H; Tao C Pharmacol Res; 2020 Aug; 158():104902. PubMed ID: 32417504 [TBL] [Abstract][Full Text] [Related]
34. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer. Wang M; Li Y; Wang M; Liu K; Hoover AR; Li M; Towner RA; Mukherjee P; Zhou F; Qu J; Chen WR Acta Biomater; 2022 Jan; 138():453-462. PubMed ID: 34757232 [TBL] [Abstract][Full Text] [Related]
35. Biomimetic Nano-Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR-II Photothermal Immunotherapy. Wei X; Huang H; Guo J; Li N; Li Q; Zhao T; Yang G; Cai L; Yang H; Wu C; Liu Y Small; 2023 Dec; 19(49):e2304370. PubMed ID: 37587781 [TBL] [Abstract][Full Text] [Related]
36. Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy. Zeng B; Pian L; Liu Y; Wang S; Wang N; Liu C; Wu H; Wan H; Chen L; Huang W; Gao Z; Yin X; Jin M J Nanobiotechnology; 2024 Sep; 22(1):558. PubMed ID: 39267061 [TBL] [Abstract][Full Text] [Related]
37. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy. Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476 [TBL] [Abstract][Full Text] [Related]
38. Multifunctional Thermosensitive Liposomes Based on Natural Phase-Change Material: Near-Infrared Light-Triggered Drug Release and Multimodal Imaging-Guided Cancer Combination Therapy. Dai Y; Su J; Wu K; Ma W; Wang B; Li M; Sun P; Shen Q; Wang Q; Fan Q ACS Appl Mater Interfaces; 2019 Mar; 11(11):10540-10553. PubMed ID: 30807086 [TBL] [Abstract][Full Text] [Related]